Feline CKD, Vomiting, and a Meloxicam Prescription
Mrs. Alvarez brings her 4.6 kg, 12-year-old spayed female domestic shorthair cat, 'Miso,' to your clinic. Miso has IRIS stage 3 chronic kidney disease (creatinine 3.9 mg/dL, urine specific gravity 1.012) and bilateral stifle osteoarthritis. The veterinarian prescribes compounded meloxicam oral suspension 0.5 mg/mL at 0.05 mg/kg PO once daily for 14 days, then every other day, with a recheck in 10 days. The owner reports Miso is drinking well but has vomited twice this week and is eating about 75% of her usual intake. The clinic has 1 mL and 3 mL oral syringes, but the pharmacy only stocks the 0.5 mg/mL suspension in a 10 mL bottle. The owner asks whether she can use her own leftover 1.5 mg/mL dog meloxicam suspension instead to save money and whether the medication is safe because 'it's just an anti-inflammatory.'
1. Calculate the prescribed dose in milligrams and the volume to dispense per dose from the 0.5 mg/mL suspension. Identify the practical dispensing problem and at least three safety concerns you would discuss with the owner before she gives the first dose.
Read the worked answer
Dose calculation
- Dose: 4.6 kg × 0.05 mg/kg = 0.23 mg per dose.
- Volume from 0.5 mg/mL: 0.23 mg ÷ 0.5 mg/mL = 0.46 mL per dose.
Practical dispensing problem
0.46 mL is a very small volume. A 1 mL oral syringe with 0.01–0.02 mL graduations is more appropriate than a 3 mL syringe; otherwise the owner can easily double the dose by misreading the meniscus. The bottle should be shaken according to the label, and the exact volume should be demonstrated and documented.
Safety concerns to discuss
- Do not substitute the 1.5 mg/mL dog product casually. It is three times as concentrated, so the same cat would need only 0.15 mL - an even harder volume to measure accurately. A measuring error with the stronger product could cause a threefold overdose.
- NSAIDs and CKD are a risk. Meloxicam inhibits COX and reduces renal prostaglandins that help maintain renal blood flow. In a cat with stage 3 CKD, vomiting, and reduced intake, dehydration and reduced renal perfusion increase the risk of acute kidney injury.
- GI ulceration and monitoring. Vomiting, anorexia, melena, diarrhea, lethargy, or abdominal pain should prompt discontinuation and veterinary examination. The owner should not combine meloxicam with corticosteroids, other NSAIDs, or human pain relievers.
- The 14-day then every-other-day plan still requires monitoring. Recheck renal values, weight, hydration, and pain control; the dose is not a substitute for addressing dehydration or dental pain.
2. The owner calls on day 5 saying Miso has vomited four times, is hiding, and has not eaten since yesterday. List your triage questions and the advice you would give; explain the pharmacologic reason meloxicam may be contributing.
Read the worked answer
Triage questions
- How many times has Miso vomited, and is the vomit food, bile, blood, or coffee-ground material?
- Any diarrhea, melena, or blood in the stool?
- Is she drinking? Is she urinating normally?
- Exactly how much meloxicam was given, with what syringe, and when was the last dose?
- Any other medications, supplements, or human drugs given?
- Any weakness, collapse, abdominal pain, or abnormal breathing?
Advice
Stop meloxicam and do not give another dose. Do not give human NSAIDs such as ibuprofen or aspirin. Arrange same-day veterinary examination because vomiting plus anorexia in a CKD cat can rapidly cause dehydration and worsen renal function. The veterinarian may need to recheck renal values, electrolytes, PCV/total protein, hydration, and blood pressure, and may consider antiemetic and GI-protectant therapy.
Why meloxicam may contribute
Meloxicam is a COX-inhibiting NSAID. COX-1 and COX-2 products include prostaglandins that support renal blood flow and gastric mucosal protection. In a dehydrated or CKD cat, blocking prostaglandin-mediated afferent arteriolar dilation can reduce glomerular filtration and precipitate renal worsening. Reduced gastroprotection also increases the risk of nausea, vomiting, and ulceration. The clinical sign is not proof that meloxicam caused the problem, but it is a sufficient signal to stop the drug and investigate promptly.